TuHURA Biosciences, Inc./NV - Common Stock, par value $0.001 per share (HURA)
CUSIP: 898920103
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 66,600,088
- Total 13F shares
- 6,118,579
- Share change
- -272,349
- Total reported value
- $15,175,582
- Price per share
- $2.48
- Number of holders
- 67
- Value change
- -$534,149
- Number of buys
- 37
- Number of sells
- 17
Quarterly Holders Quick Answers
What is CUSIP 898920103?
CUSIP 898920103 identifies HURA - TuHURA Biosciences, Inc./NV - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 898920103:
Top shareholders of HURA - TuHURA Biosciences, Inc./NV - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13D/G
13F
|
The Vanguard Group · Company |
4.4%
|
2,269,666
|
$5,628,772 | +$87,856 | 30 Sep 2025 | |
| BlackRock, Inc. |
13F
|
Company |
2%
|
1,338,226
|
$2,984,244 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.88%
|
582,992
|
$1,300,302 | — | 30 Jun 2025 | |
| FIFTH THIRD BANCORP |
13F
|
Company |
0.71%
|
473,559
|
$1,056,037 | — | 30 Jun 2025 | |
| CA Patel F&F Investments, LLC |
13D/G
|
— |
0.9%
|
447,232
|
$1,028,634 | $0 | 12 Jun 2025 | |
| KP Biotech Group LLC |
13D/G
|
— |
0.9%
|
447,232
|
$1,028,634 | $0 | 12 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.38%
|
256,004
|
$570,888 | — | 30 Jun 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.38%
|
252,109
|
$562,202 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.34%
|
228,380
|
$509,287 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.3%
|
201,214
|
$448,707 | — | 30 Jun 2025 | |
| Apollon Wealth Management, LLC |
13F
|
Company |
0.17%
|
115,274
|
$257,061 | — | 30 Jun 2025 | |
| Suncoast Equity Management |
13F
|
Company |
0.16%
|
104,409
|
$232,832 | — | 30 Jun 2025 | |
| Anthony Scott Praill |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
997,533
mixed-class rows
|
$187,714 | — | 01 Aug 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.12%
|
79,032
|
$176,241 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.07%
|
48,284
|
$107,673 | — | 30 Jun 2025 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.07%
|
43,700
|
$97,451 | — | 30 Jun 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.05%
|
35,571
|
$79,323 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
34,121
|
$76,090 | — | 30 Jun 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.05%
|
33,599
|
$74,926 | — | 30 Jun 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.05%
|
33,575
|
$74,872 | — | 30 Jun 2025 | |
| Hurlow Wealth Management Group, Inc. |
13F
|
Company |
0.05%
|
31,444
|
$70,120 | — | 30 Jun 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.04%
|
25,765
|
$57,456 | — | 30 Jun 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.04%
|
24,776
|
$55,246 | — | 30 Jun 2025 | |
| Invst, LLC |
13F
|
Company |
0.04%
|
23,400
|
$52,182 | — | 30 Jun 2025 | |
| Warberg Asset Management LLC |
13F
|
Company |
0.03%
|
20,000
|
$44,800 | — | 30 Jun 2025 | |
| Saiid Zarrabian |
3/4/5
|
Head of Strategic Partnerships, Director |
—
class O/S missing
|
56,090
|
$37,973 | — | 06 Dec 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.02%
|
15,075
|
$33,617 | — | 30 Jun 2025 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.02%
|
13,987
|
$31,191 | — | 30 Jun 2025 | |
| Merck & Co., Inc. |
13F
|
Company |
0.02%
|
13,950
|
$31,109 | — | 30 Jun 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.02%
|
13,501
|
$30,108 | — | 30 Jun 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.02%
|
13,128
|
$30,000 | — | 30 Jun 2025 | |
| INTECH INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.02%
|
12,852
|
$28,660 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.02%
|
12,138
|
$27,068 | — | 30 Jun 2025 | |
| Cyndeo Wealth Partners, LLC |
13F
|
Company |
0.02%
|
10,627
|
$23,698 | — | 30 Jun 2025 | |
| HANCOCK WHITNEY CORP |
13F
|
Company |
0.02%
|
10,627
|
$23,698 | — | 30 Jun 2025 | |
| TT Capital Management LLC |
13F
|
Company |
0.02%
|
10,000
|
$22,300 | — | 30 Jun 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.01%
|
9,119
|
$20,335 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
8,873
|
$19,786 | — | 30 Jun 2025 | |
| Accent Capital Management, LLC |
13F
|
Company |
0.01%
|
7,000
|
$15,610 | — | 30 Jun 2025 | |
| STRS OHIO |
13F
|
Company |
0.01%
|
4,800
|
$10,704 | — | 30 Jun 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.01%
|
3,812
|
$8,501 | — | 30 Jun 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
2,861
|
$6,380 | — | 30 Jun 2025 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
2,622
|
$5,847 | — | 30 Jun 2025 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0%
|
1,603
|
$3,575 | — | 30 Jun 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
962
|
$2,144 | — | 30 Jun 2025 | |
| AMALGAMATED BANK |
13F
|
Company |
0%
|
877
|
$2,000 | — | 30 Jun 2025 | |
| FMR LLC |
13F
|
Company |
0%
|
715
|
$1,594 | — | 30 Jun 2025 | |
| New England Capital Financial Advisors LLC |
13F
|
Company |
0%
|
202
|
$452 | — | 30 Jun 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0%
|
78
|
$174 | — | 30 Jun 2025 | |
| Sterling Capital Management LLC |
13F
|
Company |
0%
|
62
|
$138 | — | 30 Jun 2025 |
Institutional Holders of TuHURA Biosciences, Inc./NV - Common Stock, par value $0.001 per share (HURA) as of Q3 2025
As of 30 Sep 2025,
TuHURA Biosciences, Inc./NV - Common Stock, par value $0.001 per share (HURA) was held by
67 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,118,579 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Bank of New York Mellon Corp, NORTHERN TRUST CORP, UBS Group AG, Apollon Wealth Management, LLC, Suncoast Equity Management, and CHARLES SCHWAB INVESTMENT MANAGEMENT INC.
This page lists
67
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
48
Q3 2025 holders
67
Holder diff
19
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.